Vimarsana
Biggest News Aggregation in the World

Page 16 - Performance Advisors News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Performance Advisors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Performance Advisors Today - Breaking & Trending Today

American Well Co. (NYSE:AMWL) CEO Ido Schoenberg Sells 40,720 Shares - Vimarsana News

American Well Co. (NYSE:AMWL) CEO Ido Schoenberg Sells 40,720 Shares

American Well Co. (NYSE:AMWL – Get Rating) CEO Ido Schoenberg sold 40,720 shares of American Well stock in a transaction that occurred on Monday, April 18th. The stock was sold at an average price of $3.58, for a total transaction of $145,777.60. Following the transaction, the chief executive officer now directly owns 2,509,580 shares in […]

ProShares UltraPro QQQ (NASDAQ:TQQQ) Short Interest Update - Vimarsana News

ProShares UltraPro QQQ (NASDAQ:TQQQ) Short Interest Update

ProShares UltraPro QQQ (NASDAQ:TQQQ – Get Rating) was the target of a large decrease in short interest in March. As of March 31st, there was short interest totalling 11,660,000 shares, a decrease of 29.2% from the March 15th total of 16,470,000 shares. Based on an average daily volume of 116,666,100 shares, the short-interest ratio is […]

Avantax Planning Partners Inc. Increases Stake in JPMorgan Chase & Co. (NYSE:JPM) - Vimarsana News

Avantax Planning Partners Inc. Increases Stake in JPMorgan Chase & Co. (NYSE:JPM)

Avantax Planning Partners Inc. raised its holdings in JPMorgan Chase & Co. (NYSE:JPM) by 3.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 35,957 shares of the financial services provider’s stock after buying an additional 1,271 shares during the quarter. Avantax Planning Partners […]

Amyris (NASDAQ:AMRS) Rating Increased to Sell at StockNews.com - Vimarsana News

Amyris (NASDAQ:AMRS) Rating Increased to Sell at StockNews.com

Amyris (NASDAQ:AMRS – Get Rating) was upgraded by StockNews.com to a “sell” rating in a research note issued on Thursday. Separately, Zacks Investment Research lowered shares of Amyris from a “hold” rating to a “strong sell” rating in a research report on Thursday, March 3rd. Two research analysts have rated the stock with a sell […]

Brokers Set Expectations for Amyris, Inc.'s FY2024 Earnings (NASDAQ:AMRS) - Vimarsana News

Brokers Set Expectations for Amyris, Inc.'s FY2024 Earnings (NASDAQ:AMRS)

Amyris, Inc. (NASDAQ:AMRS – Get Rating) – Oppenheimer reduced their FY2024 earnings estimates for shares of Amyris in a research note issued on Tuesday, March 1st. Oppenheimer analyst C. Rusch now anticipates that the biotechnology company will earn $0.22 per share for the year, down from their prior forecast of $0.27. Amyris (NASDAQ:AMRS – Get […]